Mutations in four genes account for over 90 % of all CMT molecular diagnoses, including peripheral myelin protein 22 (PMP22), gap junction β-1 (GJB1), myelin protein zero (MPZ), and mitofusion 2 (MFN2) [165]. The gene discussed is MPZ; the disease is Charcot-Marie-Tooth disease.